CS3抗原基因的表达及纤毛装配元件的研究

在肠毒素大肠杆菌(ETEC)的已知定居因子中,CS3是临床分离株中最常见的抗原之一。为了研究CS3纤毛装配的基本元件,绘制了CS3亚基结构基因和辅助蛋白编码区的限制酶谱。通过亚克隆的亚基基因和不同辅助蛋白基因之闻的互补性表达结果,确定了CS3纤毛装配所需要的辅助蛋白的DNA功能片段。微细胞分析结果显示,CS3基因的有效表达和纤毛的装配至少需要6条蛋白多肽分子量分别为15kDa,17kDa,24kDa,27kDa,48kDa和90kDa。除了15／17kDa的蛋白多肽为CS3亚基外,其余的蛋白多肽参与CS3亚基的转运及纤毛的装配。根据以上结果初步确定了上述相关基因的相对位置。     

CS3纤毛抗原表达调控机理的研究

定居因子抗原(CFA)是肠毒素大肠杆菌(ETEC)的重要毒性因子和保护性抗原,大多以菌毛的形式存在。此类抗原的表达及菌毛的装配需要2类基因的共同作用,即亚基结构基因和辅助蛋白结构基因。亚基是纤毛抗原的基本组成单位,而辅助蛋白则参与亚基蛋白分子的输送及装配过程。CS3亚基结构基因位于辅助蛋白结构基因的下游,处于CS3操纵子的3′端。CS3亚基结构基因的核苷酸序列分析揭示,在其翻译起始位点的上游存在着rbs位点及原核     

CS3纤毛抗原表达调控机理的研究

CS3亚基结构基因的核苷酸序列分析表明,在其翻译起始位点的上游存在着rbs位点及原核启动子的—10区和—35区DNA序列。凝胶阻滞和启动报告基因表达的实验确证了CS3亚基结构基因具有自身的启动子(Ps),怛它的作用受其上游区域的抑制。核苷酸序列分析发现,在Ps—35区上游550bp和840bp处各存在一个富A-T簇。结合原核启动子的一般作用规律推知,CS3的表达可能受DNA结合蛋白型的正向调节因子的作用,互补实验结果表明cfaD基因不仅可消除上游区对Ps的抑制,而且可大幅度地提高Ps的启动能力。在分析表达调控的基础上获得CS3重组高效表达。同时提出了其表达调控模型。     

《生物技术通讯》1998年分类索引——(第9卷 总第33～36期)

研究报告 n·RNA蔷=}f译起始区i级结构改变对干扰素基因在大肠杆菌中翻译的影响……张平武 王易伦 陆德如(1) 登革2型病毒43株prM基因片段在痘苗中的克隆与表达……………………孙 蕾 杨佩英 秦鄂德等(6) Cs3纤毛抗原表达调控机理的研究……………………………………………董自正 张兆山 李淑琴等(10) CS3抗原基因的表达及纤毛装配元件的研究…………………………………董自正 张兆山 李淑琴等(1 5) CS3菌毛可以作为异源抗原决定簇的嵌合表达载体…………………………董自正 张兆山 李淑琴等(20) 人白血病抑制因子的改构与在大肠杆菌中…     

腈水合酶NHaseK在大肠杆菌中的功能表达

腈水合酶由α亚基和β亚基组成,活化元件对其功能表达至关重要,研究腈水合酶基因簇中各元件的表达比例对酶重组表达的影响具有重要意义。以来源于Klebsiella oxytoca KCTC 1686的腈水合酶（NHaseK）为研究对象,构建了多种表达策略,以期实现α亚基、β亚基和活化元件17k差异表达。利用pETDuet-1质粒具有双T7启动子的特点,将上述基因以八种不同的组合方式分别插入于两个启动子之后。当将三段基因同时插入于第一个启动子之后时,亚基表达量均衡,比活力为0.78 U/mg蛋白,是亚基表达量比例为5：3时的124%。在此基础上,在第二个启动子之后插入活化元件基因,活化元件表达水平提升2倍,比活提升5%,为0.82 U/mg蛋白。当将α亚基和β亚基插入于不同启动子之后时,酶活仅为对照组的10%,说明NHaseK的亚基必须同时转录才可形成成熟蛋白。进一步考察质粒拷贝数对大肠杆菌表达NHaseK的影响,确定15~20的质粒拷贝数足够实现NHaseK的功能表达。结果表明,亚基的均衡表达以及活化元件的充分表达对NHaseK的重组表达具有积极作用。     

CS3菌毛可以作为异源抗原决定簇的表达载体

CS3是肠毒素源性大肠杆菌的菌毛蛋白 ,是一种很强的免疫原 .利用CS3菌毛作为异源抗原决定簇载体 ,在计算机分析预测CS3亚基的抗原表位区、二级结构的基础上 ,运用PCR定点突变在CS3亚基结构基因中引入了SacⅡ酶切位点序列 ,插入霍乱毒素B亚基抗原表位CTP3的DNA序列 ,构建了表达CS3/CTP3的重组菌株 .电镜和免疫电镜观察证明 ,CS3/CTP3以杂合菌毛的形式存在于菌体表面 .SDS聚丙烯酰胺凝胶电泳显示了CS3/CTP3杂合蛋白的存在 .口服和腹腔注射免疫Balb/c小鼠 ,该重组菌株可诱发抗CS3和抗CTP3的双重免疫应答 .结果表明CS3可以作为表达异源抗原决定簇的表达载体 ,可望成为研制口服粘膜免疫多价疫苗的新型系统     

野生大豆(Glycine soja Sieb et ZUCC)球蛋白A_5 A_4 B_3 cDNA的研究(简报)

大豆球蛋白是大豆种子中主要的贮藏蛋白。它们在某些作物中占种子干重20%以上。已经知道大豆球蛋白由6个亚基组成。每个亚基由一或两个酸性多肽(A)和一个碱性多肽(B)组成,多肽之间由二硫键联结。这些亚基是从编码A-B亚基前体的mRNA合成,然后经过转录后加工剪切形成A肽和B肽。至今所有关于球蛋白的基因结构与表达的报道都集中于栽培大豆上。由于我国有丰富的大豆     

CS3菌毛可以作为异源抗原决定簇的嵌合表达载体

CS3是肠毒素源性大肠杆菌的菌毛蛋白,是一种很强的免疫原。研究了利用CS3菌毛作为异源抗原决定簇载体的可能性。在计算机分析预测CS3亚基的抗原表位区、二级结构的基础上,运用PCR定点突变在CS3亚基结构基因中引入了SacⅡ酶切位点序列,插入编码霍乱毒素B亚基抗原表位CTP3的DNA序列,构建了表达CS3/CTP3的重组菌株。电镜和免疫电镜观察证明,CS3/CTP3以杂合菌毛的形式存在于菌体表面,SDS聚丙烯酰胺凝胶电泳显示了CS3/CTP3杂合蛋白的存在。口服和腹腔注射免疫Bal b/c小鼠,该重组菌株可诱发抗CS3和抗CTP3的双重免疫应答。结果表明CS3可以作为表达异源抗原决定簇的表达载体,可望成为研制口服粘膜免疫多价疫苗的新型系统。     

苏云金杆菌辅助蛋白P19对杀虫晶体蛋白Cry11Aa表达的影响

苏云金杆菌以色列亚种的p19基因、cry11Aa基因和p20基因位于同一操纵子上,据推测辅助蛋白P19可能与Cry11Aa蛋白的晶体化相关。本研究利用穿梭载体pHT3101构建了两个重组质粒pHcy1和pHcy3,两质粒均携带cry11Aa基因,但后者完全缺失了cry11Aa基因上游的p19基因。将重组质粒电激转化至苏云金杆菌无晶体突变株4Q7中进行蛋白表达,SDS-PAGE结果表明在4Q7(pHcy1)和4Q7(pHcy3)中均能检测到正常表达的Cry11Aa蛋白,但单位体积培养液的Cry11Aa蛋白在辅助蛋白P19存在时的表达量明显高于其单独表达的表达量;透射电镜观察显示两菌株中的Cry11Aa蛋白形成了大小相近、形状相似的双梯形晶体;另外,生物测定结果表明重组菌株4Q7(pHcy1)和4Q7(pHcy3)对三龄致倦库蚊的杀虫活性没有显著性差异。该现象说明辅助蛋白P19的缺失对Cry11Aa蛋白的晶体形成和杀蚊活性没有影响,但P19作为分子伴侣在一定程度上帮助提高了Cry11Aa蛋白的表达水平。     

小鼠17β-hsd10的克隆、表达及双抗夹心ELISA方法的建立

原核表达小鼠17β-羟基类固醇脱氢酶(17β-hsd10),制备抗17β-hsd10多克隆抗体,建立17β-hsd10双抗夹心酶联免疫检测方法 (Enzyme linked immunosorbent assay,ELISA)。采用RT-PCR技术克隆得到小鼠肝脏17β-hsd 10基因,构建原核表达体系p ET15b-17β-hsd10/Escherichia coli BL21(DE3),IPTG诱导重组蛋白表达,并优化表达条件;目的蛋白用His融合蛋白纯化柱(His-Binding-resin)纯化并免疫BALB/c小鼠和新西兰大耳白兔,免疫血清总Ig G采用硫酸铵沉淀法纯化,用获得的高效价鼠源和兔源两种多克隆抗体,建立17β-hsd10双抗夹心酶联免疫检测方法。表达蛋白约为29.5 k Da,纯化后浓度为1.5 mg/m L,鼠源和兔源多克隆抗体效价分别为1.25×104和2.5×104,建立的检测方法对于多种羟基类固醇脱氢酶无交叉反应,特异性良好,可检出含量约为0.05-0.1μg/m L的阳性血清。建立的17β-hsd10双抗夹心ELISA方法,简便、快速、敏感,适合实验室研究科研广泛应用。并可能为检测阿尔茨海默病提供新思路和方法。     

Characterization and molecular cloning of the PCF8775 CS5 antigen from an enterotoxigenic Escherichia coli 0115:H40 isolated in Central Australia

The genes determining the biosynthesis of the colonization factor CS5 have been cloned from Escherichia coli 0115:H40:PCF8775 isolated during an outbreak of diarrhoea among aboriginal children in Central Australia. Electron microscopy has shown purified CS5 to be of semi-rigid fimbrial type. NH2-terminal analysis has shown the CS5 determinant to be distinct from other fimbriae, although there is some conservation of certain residues. Expression in minicells of the cloned fimbrial genes encoded on pPM1312 has shown that proteins of 70 and 46.5 kD which co-purity with the 23 kD major fimbrial subunit protein are also co-expressed along with proteins of 45, 31, 17 and 14 kD. The major CS5 subunit is synthesized in precursor form (approximately 26 kD). A synthetic oligonucleotide to the NH2-terminal amino acid coding sequence of the purified protein has been used in Southern hybridization analyses to define the region on pPM1312 encoding the structural gene for the major pilin subunit.     

Genes for biosynthesis and assembly of CS3 pili of CFA/II enterotoxigenic Escherichia coli: novel regulation of pilus production by bypassing an amber codon

The complete nucleotide sequence of the 4746bp HindIII fragment encoding the genes for the biosynthesis and assembly of CS3 pili has been determined. By site-directed mutagenesis in conjunction with analysis of the plasmid-encoded proteins in minicells, the actual reading frames for the various products have been determined. This demonstrated that the genes for four of the proteins (63 kD, 48 kD, 33 kD, and 20 kD in size) are encoded entirely within the same open reading frame as a fifth protein (104 kD). However, for synthesis of this latter protein, suppression or readthrough of an internal amber codon is required. Termination at this codon is also necessary for synthesis of the former proteins. Two further proteins are also encoded within the HindIII fragment: a 27 kD precursor of a periplasmic protein and the 17.5kD precursor of the major CS3 fimbrial subunit.     

Analysis of the first two genes of the CS1 fimbrial operon in human enterotoxigenic Escherichia coli of serotype 0139: H28

An oligonucleotide, derived from the N-terminal amino acid sequence of the CS1 fimbrial subunit protein was used to identify the subunit gene on recombinant plasmid pDEP23 containing the structural genes of the CS1 fimbrial operon. The nucleotide sequence of the subunit gene (csoA), encoding a protein of 171 amino acids, was determined. Flanking it upstream, a gene (csoB) encoding a protein of 238 amino acids was found. The CsoB and CsoA proteins are homologous to the CfaA and CfaB proteins in the CFA/I fimbrial operon. For all the CS1 producing strains investigated the structural genes are located on plasmids. Like CFA/I fimbriae, CS1 fimbriae are only expressed in the presence of a positive regulator, CfaD for CFA/I and Rns for CS1, respectively. The promoter region upstream of the csoB gene was cloned in front of the promoterless alkaline phosphatase (phoA) gene of the promoter-probe vector pCB267. PhoA activity was enhanced approximately two-fold by the introduction of compatible plasmids containing either rns or cfaD.     

CS3 fimbriae of enterotoxigenic Escherichia coli as chimeric expression carriers of heterologous antigenic determinants

CS3 fimbriae, which are the strong immunogen, are produced by human enterotoxigenic Escherichia coli (ETEC). The possibility of using CS3 as a carrier of foreign antigenic determinants was investigated. A SacⅡ site sequence was inserted into the structural gene of CS3 subunit by site-specific mutagenesis based on analyzing and predicting the properties of the proteins. A recombinant strain expressing CS3/CTP3 hybrid fimbriae was constructed by inserting the sequence encoding CTP3 into the SacII site created by directed mutagenesis in the structural gene of CS3 subunit and transforming the recombinant plasmid into the host of DH5α. The result of SDS-PAGE showed that the hybrid CS3/CTP3 molecules were the fusion proteins with molecular masses of about 18.5 ku. Inoculating mice orally and intraperitoneally showed that both antibodies against CS3 and CTP3 were elicited. These results indicate that CS3 pili could be an exposure vector for heterologous antigenic determinants and become a powerful tool for the development of oral vaccines directed against mucosal pathogens.     

CS3 fimbriae of enterotoxigenicEscherichia coli as chimeric expression carriers of heterologous antigenic determinants

CS3 fimbriae, which are the strong immunogen, are produced by human enterotoxigenicEscherichia coli (ETEC). The possibility of using CS3 as a carrier of foreign antigenic determinants was investigated. A SacII site sequence was inserted into the structural gene of CS3 subunit by site-specific mutagenesis based on analyzing and predicting the properties of the proteins. A recombinant strain expressing CS3/CTP3 hybrid fimbriae was constructed by inserting the sequence encoding CTP3 into the SacII site created by directed mutagenesis in the structural gene of CS3 subunit and transforming the recombinant plasmid into the host of DH5α. The result of SDS-PAGE showed that the hybrid CS3/CTP3 molecules were the fusion proteins with molecular masses of about 18.5 ku. Inoculating mice orally and intraperitoneally showed that both antibodies against CS3 and CTP3 were elicited. These results indicate that CS3 pili could be an exposure vector for heterologous antigenic determinants and become a powerful tool for the development of oral vaccines directed against mucosal pathogens.     

Morphological and immunocytochemical analysis of Escherichia coli-specific surface antigens in wildtype strains and in recombinant Vibrio cholerae

Adhesion is the first step in the pathogenesis of enterotoxigenic Escherichia coli infections. The genes encoding the most prevalent adhesion factors CFA/I, CS3 and CS6 were cloned into Vibrio cholerae strain CVD 103–HgR and expression of fimbriae was investigated in wildtype and recombinant strains by transmission electron microscopy in conjunction with immunolabelling and negative staining. Negative staining was effective in revealing CFA/I and CS3, but not CS6. Although morphology of fimbriae differed between wildtype and recombinant strains, corresponding surface antigens were recognized by specific antibodies. The present study provides evidence that ETEC-specific fimbriae can adequately be expressed in an attenuated V. cholerae vaccine strain and that immunoelectron microscopy is a critical tool to validate the surface expression of antigens in view of their possible suitability for recombinant vaccines.     

Assessing the expression of enterotoxigenic Escherichia coli-specific surface antigens in recombinant strains by transmission electron microscopy and immunolabeling.

Infections with enterotoxigenic Escherichia coli (ETEC) are a major cause of travelers' diarrhea worldwide. Colonization of the small intestine mucosa is dependent on specific colonization factor antigens (CFA) and coli surface (CS) antigens. CFA/1, CS3, and CS6 are the most prevalent fimbrial antigens found in clinical isolates. The goal of our study was to visualize the morphology of CS3 and CS6 fimbriae in wild-type and recombinant E. coli strains by means of transmission electron microscopy in conjunction with negative staining and immunolabeling. Corresponding ETEC genes were cloned into E. coli K12 strain DH10B. Expression of fimbriae was dependent on culture conditions and sample handling. Specific immunolabeling of fimbriae unequivocally demonstrated the presence of all types of surface antigens investigated. Negative staining was effective in revealing CS3 but not CS6. In addition, this technique clearly demonstrated differences in the morphology of genetically and immunologically identical CS3 surface antigens in wild-type and recombinant strains. This paper provides a basis for the assessment of recombinant vaccines.     

The genetic determinant of adhesive function in type 1 fimbriae of Escherichia coli is distinct from the gene encoding the fimbrial subunit.

The role of type 1 fimbriae in the mannose-sensitive attachment of Escherichia coli to eucaryotic cells was investigated by deletion mutation analysis of a recombinant plasmid, pSH2, carrying the genetic information for the synthesis and expression of functional type 1 fimbriae. A mutant, pUT2002, containing a deletion remote from the structural gene encoding the 17-kilodalton subunit protein of type 1 fimbriae failed to agglutinate guinea pig erythrocytes even though the bacteria expressed fimbriae morphologically and antigenically indistinguishable from those produced by the intact recombinant plasmid. Fimbriae isolated from pUT2002 failed to agglutinate guinea pig erythrocytes, but reacted with a monoclonal antibody specific for quaternary structural determinants of type 1 fimbriae. Moreover, the dissociated fimbrial subunits from this mutant were indistinguishable from normal fimbriae by their migration during electrophoresis in sodium dodecyl sulfate-polyacrylamide gels, by their reactivity with a monoclonal antibody directed against a subunit-specific epitope, and in enzyme-linked immunosorbent assays with monospecific antisera. These results indicate that the adhesive functions in type 1 fimbriae are dependent on a factor(s) encoded by a gene other than those required for synthesis, assembly, and expression of the structural 17-kilodalton subunit.     

Candidate vaccine antigens and genes in Pasteurella multocida.

Pasteurella multocida is the causative agent of fowl cholera and other diseases of production animals. Isolates are classified into five groups based on capsular antigens and into 16 serotypes based on LPS antigens. Strains causing fowl cholera are most frequently designated A:1, A:3 or A:4. Whole cell bacterins can provide some degree of protection, but only against the homologous LPS serotype. There is good evidence that cross-protective antigens are expressed only under in vivo conditions. Empirically derived, live, attenuated vaccines can protect against heterologous serotypes, but because the basis for attenuation is undefined, reversion to virulence is not uncommon. Work in our laboratory is aimed at using a variety of approaches to identify potential protective antigens or virulence genes to be used as candidates for attenuating mutations or as the basis for vaccine antigen delivery systems. The gene encoding an outer membrane protein, Oma87, which is a homologue of the D15 protective antigen of Haemophilus influenzae, was cloned and sequenced. Rabbit antiserum prepared against recombinant Oma87 could passively protect mice against infection. Type 4 fimbriae form the basis of vaccines against ovine footrot and bovine keratoconjunctivitis. We have identified type 4 fimbriae on the surface of P. multocida, purified the fimbrial subunit protein, PtfA, and determined its N-terminal amino acid sequence. Subsequent cloning of the ptfA gene and its inactivation will now be used to assess the importance of type 4 fimbriae in virulence. There has long been anecdotal evidence for the importance of capsule in virulence, but unequivocal genetic evidence for such a role is lacking. We have cloned and characterised the capsule biosynthetic locus in P. multocida A:1 and identified four bex genes involved in capsule transport and genes encoding enzymes involved in the biosynthesis and transfer of the N-acetyl glucosamine and glucuronic acid components of the capsule. It has been suggested that the low concentration of available iron in vivo acts as an environmental cue for expression of cross-protective antigens. Accordingly, we have cloned and characterised the gene encoding transferrin binding protein, Tbpl, so that its role in immunity and virulence can be investigated. Although P. multocida is not normally considered haemolytic, we have observed haemolysis under anaerobic conditions. Standard library construction and screening resulted in the identification of the mesA gene which encodes an esterase enzyme resulting in a haemolytic phenotype under anaerobic conditions. Virulence studies with mesA- mutants were performed to assess its role in pathogenesis. Using a promoterless phoA gene vector system, the cloning of proteins homologous to known surface proteins of other species as well as proteins unique to P. multocida, allowing their potential as vaccine components to be assessed.